Showing 1541-1550 of 2046 results for "".
- Eyenovia to Present Clinical Study Updates at the American Academy of Optometry Annual Meetinghttps://modernod.com/news/eyenovia-to-present-clinical-study-updates-at-the-american-academy-of-optometry-annual-meeting/2478390/Eyenovia announced that Drs. Siddarth Rathi and April Jasper will present the latest analyses and updates from the company’s clinical studies at the American Academy of Optometry Academy 2020 At Home Conference. On Wednesday, October 7, April Jasper, OD, medical monitor for the company’s C
- Johnson & Johnson Vision Presents New Myopia Progression and Contact Lens Findings at American Academy of Optometry Annual Meetinghttps://modernod.com/news/johnson-johnson-vision-presents-new-myopia-progression-and-contact-lens-findings-at-american-academy-of-optometry-annual-meeting/2478387/Johnson & Johnson Vision announced clinical data from the latest in myopia research at the American Academy of Optometry’s virtual annual meeting (Academy 2020). Investigators will also reveal findings that demonstrate how Acuvue Oasys 1-Day with Hydraluxe Technology Contact Lenses redu
- Haag-Streit UK Announces Launch of the MR Q and MR Q Supine Laser Systems in the UKhttps://modernod.com/news/haag-streit-uk-announces-launch-of-the-mr-q-and-mr-q-supine-laser-systems-in-the-uk/2478337/Haag-Streit UK (HS-UK) has announced the launch of the Meridian MR Q and MR Q supine YAG lasers in the UK. The MR Q is a fully-integrated YAG laser, which features the latest technology for posterior capsulotomy, pupillary membranectomy, and iridotomy. The laser boasts outstanding u
- SightGlass Vision Announces R&D Webinar Featuring Leading Myopia Expertshttps://modernod.com/news/sightglass-vision-announces-rd-webinar-featuring-leading-myopia-experts/2477704/SightGlass Vision announced it will hold an R&D webinar to discuss the science of and latest research in myopia, as well as provide an overview about the clinical development and commercialization program for the company’s novel glasses designed to slow the progression of myopia in chil
- Lilly Partners With NIH to Test Olumiant in Patients Hospitalized With COVID-19https://modernod.com/news/lilly-partners-with-nih-to-test-olumiant-in-patients-hospitalized-with-covid-19/2477574/Drug companies worldwide are testing existing medicines as potential treatments for COVID-19—plus working on new therapeutics—with few answers yet. Now, Eli Lilly is among the latest to kick off a trial through a partnership with federal health officials, according t
- AAO: Malaria Drugs For COVID-19 Will Not Blind Youhttps://modernod.com/news/aao-malaria-drugs-for-covid-19-will-not-blind-you/2477533/The American Academy of Ophthalmology has shared its latest information about protecting vision during the COVID-19 pandemic. Below are six topics getting a lot of attention right now, and AAO’s recommendations: Avoid touching your eyes By now you
- Experts Provide Advice on How to Handle Staff and Ensure Business Survival When the Practice Closeshttps://modernod.com/news/ootg-webcast-experts-provide-advice-on-how-to-handle-staff-and-ensure-business-survival-when-the-practice-closes/2477517/In the latest episode of Ophthalmology off the Grid, cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, touched base with practice management experts Bruce Maller and Matt Jensen who shed light on key areas of concern for practice leaders. Mr. Maller and Mr. Jensen provide insight on a variet
- New Podcast Addresses COVID-19 Impacthttps://modernod.com/news/new-podcast-addresses-covid-19-impact/2477431/In the latest installment of the Off the Grid podcast, titled “Unprecedented Times,” cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, speak with Steven J. Dell, MD, and Tal Raviv, MD, to discuss the novel coronavirus and its impact on their respective states, practices, and dail
- Regeneron’s Novel COVID-19 Antibody Program Has Potential to Enter Human Clinical Studies by Early Summerhttps://modernod.com/news/regenerons-novel-covid-19-antibody-program-has-potential-to-enter-human-clinical-studies-by-early-summer/2477404/Regeneron Pharmaceuticals announced the latest progress in its efforts to discover and develop a novel multi-antibody cocktail that can be administered as prophylaxis before exposure to the SARS-CoV-2 virus or as treatment for those already infected. Regeneron scientists have now isolated
- Alcon Announces European Launch of Vivity Presbyopia-Correcting IOL With X-WAVE Technologyhttps://modernod.com/news/alcon-announces-european-launch-of-vivity-presbyopia-correcting-iol-with-x-wave-technology/2477377/Alcon announced that the AcrySof IQ Vivity IOL is now commercially available in select European markets, with additional countries to follow throughout 2020. The latest innovation in Alcon’s portfolio of presbyopia-correcting IOLs (PC-IOLs), Vivity is the first-of-its-kind, extended range